Evaluation of the retropubic approach to robotic simple prostatectomy
There are several surgical options for the treatment of Benign Prostatic Hyperplasia (BPH). The retropubic approach to a robotic simple prostatectomy …
There are several surgical options for the treatment of Benign Prostatic Hyperplasia (BPH). The retropubic approach to a robotic simple prostatectomy …
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence…
Racial disparities in atopic disease (atopic dermatitis [AD], asthma, and allergies) prevalence are well documented. Despite strong associations betwe…
The integration of Artificial Intelligence (AI) in oncology is a developing field, impacting the doctor-patient relationship and the efficacy of cance…
To systematically review the association of pain, function, and progression in first carpometacarpal osteoarthritis with imaging biomarkers and radiog…
Available online 5 March 2024, 101344 Author links open overlay panel Ziad A. Ali MD, DPhil a, Antonio Dager MD b, Mauricio Zúñiga MD b,…
DD01 is a long-acting dual agonist of glucagon-like peptide-1 and glucagon receptors.
Little is known about the effect tubulointerstitial nephropathies have in modulating maternal-fetal outcomes in pregnancy. Therefore, we analyzed the …
Available online 21 August 2023, 101121 Author links open overlay panel Rajesh V. Swaminathan MD, FSCAI (Vice-Chair) a, Cara Anne East MD b, Dmitriy N.…
Neal D. Shore, MD, shares what he’s most looking forward to at this year’s American Urological Association Annual Meeting.
Adding the radionuclide therapy ¹⁷⁷Lu-PSMA-617 to enzalutamide improved outcomes in patients with treatment-naïve mCRPC in a phase 2 trial.